Good evening :)
Switch to
Place Order

Shilpa Medicare Ltd

SHILPAMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,465 cr, stock is ranked 476
Moderate RiskStock is 2.81x as volatile as Nifty
554.807.05 (+1.29%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,465 cr, stock is ranked 476
Moderate RiskStock is 2.81x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
30.22
PB RatioPB Ratio
3.38
Dividend YieldDiv. Yield
0.20%
Sector PESector PE
38.33
Sector PBSector PB
5.72
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation.

Investor PresentationView older 

May 31, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021810.50786.96924.85992.11105.25112.26156.13147.78
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnJun 22, 2021

Shilpa Medicare Limited has informed the Exchange regarding 'Shilpa Medicare Limited Launches, first time in the world fast dissolving Oral Thin Films of Paracetamol, Molshilᅡᆴ Oral Thin Films in India'. | Download

Shilpa Medicare Limited has informed the Exchange regarding 'Shilpa Medicare Limited Launches, first time in the world fast dissolving Oral Thin Films of Paracetamol, Molshilᅡᆴ Oral Thin Films in India'. | Download

Scheme of Arrangement 
Announced OnJun 19, 2021

Shilpa Medicare Limitedᅡᅠhereby submits the disclosure under Regulation 37(6) of SEBI (LODR) Regulations, 2015, in relation to the proposed amalgamation of M/s INM Technologies Private Limited (a wholly owned subsidiary of Shilpa Medicare Limited) with Shilpa Medicare Limited. | Download

Shilpa Medicare Limitedᅡᅠhereby submits the disclosure under Regulation 37(6) of SEBI (LODR) Regulations, 2015, in relation to the proposed amalgamation of M/s INM Technologies Private Limited (a wholly owned subsidiary of Shilpa Medicare Limited) with Shilpa Medicare Limited. | Download

Cash Dividend 
Ex. DateMar 16, 2020

Interim • Div/Share: ₹ 1.1

See all events